WallStreetZenWallStreetZen

NASDAQ: MRSN
Mersana Therapeutics Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

MRSN past revenue growth

How has MRSN's revenue growth performed historically?
Company
38.65%
Industry
145.22%
Market
17.76%
MRSN's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
MRSN's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
MRSN's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

MRSN earnings and revenue history

Current Revenue
$36.9M
Current Earnings
-$171.7M
Current Profit Margin
-465.8%

MRSN Return on Equity

Current Company
-282.4%
Current Industry
-63.5%
Current Market
188%
MRSN's Return on Equity (-282.4%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when MRSN announces earnings.

MRSN Return on Assets

Current Company
-62.6%
Current Industry
2.9%
MRSN is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

MRSN Return on Capital Employed

Current Company
-103.19%
Current Industry
19.5%
MRSN's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

MRSN vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
MRSN$36.86M-$163.30M-$171.67M+28.32%N/A
LXRX$1.20M-$163.46M-$177.12M-54.71%N/A
BMEA$0.00-$113.05M-$117.26MN/AN/A
ITOS$12.60M-$108.13M-$112.64M-80.89%N/A
MREO$10.00M-$27.34M-$29.47M-53.16%N/A
View Top Biotech Stocks

MRSN earnings dates

Next earnings date
Jun 11, 2024

Mersana Therapeutics Earnings & Revenue FAQ

What were MRSN's earnings last quarter?

On Invalid Date, Mersana Therapeutics (NASDAQ: MRSN) reported Q4 2023 earnings per share (EPS) of -$0.15, up 65.12% year over year. Total Mersana Therapeutics earnings for the quarter were -$19.54 million. In the same quarter last year, Mersana Therapeutics's earnings per share (EPS) was -$0.43.

If you're new to stock investing, here's how to buy Mersana Therapeutics stock.

What was MRSN's earnings growth in the past year?

As of Q2 2024, Mersana Therapeutics's earnings has grown year over year. Mersana Therapeutics's earnings in the past year totalled -$171.67 million.

What is MRSN's earnings date?

Mersana Therapeutics's earnings date is Invalid Date. Add MRSN to your watchlist to be reminded of MRSN's next earnings announcement.

What was MRSN's revenue last quarter?

On Invalid Date, Mersana Therapeutics (NASDAQ: MRSN) reported Q4 2023 revenue of $10.70 million up 27.14% year over year. In the same quarter last year, Mersana Therapeutics's revenue was $14.69 million.

What was MRSN's revenue growth in the past year?

As of Q2 2024, Mersana Therapeutics's revenue has grown 38.65% year over year. This is 106.57 percentage points lower than the US Biotechnology industry revenue growth rate of 145.22%. Mersana Therapeutics's revenue in the past year totalled $36.86 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.